| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/15/2008 | WO2008055931A1 Use of natural, recombinant and synthetic resilins in cosmetics |
| 05/15/2008 | WO2008055889A1 Compositions and methods of treating oncological, inflammatory and autoimmune diseases mediated by sema4a |
| 05/15/2008 | WO2008055361A1 E3 UBIQUITM LIGASE MKRNL AS A MARKER FOR MAMMALIAN STEM CELL PLUπPOTENCY AND METHODS AND USES THEREOF |
| 05/15/2008 | WO2008055314A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 05/15/2008 | WO2008039838A3 Synthetic streptococcus pneumoniae vaccine |
| 05/15/2008 | WO2008033395A3 Melanocortin and transferrin fusion proteins |
| 05/15/2008 | WO2008012542A3 Polysaccharide derivatives of erythropoietin |
| 05/15/2008 | WO2008008082A3 Clostridial toxin activatable clostridial toxins |
| 05/15/2008 | WO2008005527A3 Glucagon-like peptides and uses thereof |
| 05/15/2008 | WO2007147064A3 Modified soy proteins and methods of use |
| 05/15/2008 | WO2007126792A3 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases |
| 05/15/2008 | WO2007104945A3 Proteins, nucleic acids and medicaments |
| 05/15/2008 | WO2007103767A3 Role of microrna in plant salt tolerance |
| 05/15/2008 | WO2007089659A3 Tat-039 and methods of assessing and treating cancer |
| 05/15/2008 | WO2007031727A3 System for delivering neuronal calcium sensor - 1 (ncs - 1) |
| 05/15/2008 | US20080115244 Therapeutic antibodies comprising protective proteins for use in treatment and prevention of dental caries and streptococal infection; dentristry |
| 05/15/2008 | US20080115243 Transgenic Plants Expressing Intein Modified Proteins and Associated Processes for Bio-Pharmaceutical Production |
| 05/15/2008 | US20080115237 Novel ecdysone receptor-based inducible gene expression system |
| 05/15/2008 | US20080115231 Using peroxisome proliferator activated receptor as tool in detecting compounds which enhance food intake and/or body weight gain; diagnosing and treating eating disorders |
| 05/15/2008 | US20080114157 Rapid glycopeptide optimization via neoglycosylation |
| 05/15/2008 | US20080114155 Modified Human Interferon Polypeptides and Their Uses |
| 05/15/2008 | US20080114154 Protease resistance |
| 05/15/2008 | US20080114153 Potent, durable cytotoxic agents; tissue targeted therapy; tumors, autoimmune diseases, graft versus host disease, viral and parasite infections |
| 05/15/2008 | US20080114078 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113928 Modified Cea/B7 Vector |
| 05/15/2008 | US20080113917 A fusion protein expressed in a protease resistant scaffold and protease inhibitor is selected from the group consisting of Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor; capable of modulating human hair growth |
| 05/15/2008 | US20080113910 Polypeptides or peptides with no risk for viral infection, pathogens, prions; not evoke immune response; gelatine consists of native human collagen sequences; coating on scaffolds for tissue engineering, implant, transplant materials; component of drug delivery systems for inhibition of cancer metastasis |
| 05/15/2008 | US20080113909 Compositions and Methods for Treating Stat-6 Associated Diseases or Conditions |
| 05/15/2008 | US20080113908 Use of CRF receptor agonists for the treatment or Prophylaxis of diseases, for example Neurodegenerative diseases |
| 05/15/2008 | US20080113906 Sushi Peptide Multimer |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080113449 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders |
| 05/15/2008 | US20080113430 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 05/15/2008 | US20080113429 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113424 Isolating dermatophagoides protein via anion exchange and hydrophobic gel adsorption |
| 05/15/2008 | US20080113410 Method for Rational Pegylation of Proteins |
| 05/15/2008 | US20080113406 Modified bacteriocins and methods for their use |
| 05/15/2008 | US20080113405 Gene-Cassette For Enhancement Of Protein Production |
| 05/15/2008 | US20080113388 Nematode ATP Synthase Subunit E-Like Sequences |
| 05/15/2008 | US20080113385 Immunoglobulin for use in prevention and treatment inflammatory disease |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080113342 Plant Genome Sequence and Uses Thereof |
| 05/15/2008 | US20080113340 Diagnosis and treatment of cervical cancer |
| 05/15/2008 | US20080112982 An genetically engineered bacterial flagella that is greater in length than flagella from a naturally occurring organism; comprises a mutation in FlgG protein, a binder of the nanotubes and a reporter molecule; drug delivery; medical equipment; miniaturization of electrical devices; fabric insulators |
| 05/15/2008 | US20080112973 Chimeric papillomavirus-like particles |
| 05/15/2008 | US20080112971 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses; |
| 05/15/2008 | US20080112965 Chlamydia OMP antigen |
| 05/15/2008 | US20080112964 Mutant Pneumolysin Proteins |
| 05/15/2008 | US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 05/15/2008 | US20080112929 Shielded adenoviral vectors and methods of use |
| 05/15/2008 | US20080112926 Preparing chimeric polypeptide comprising glycosaminoglycan-binding proteins (GAG) for use in prevention and treatment of skin, nervous system and inflammatory disorders |
| 05/15/2008 | CA2698826A1 New antigens for paratuberculosis diagnosis and vaccination |
| 05/15/2008 | CA2669806A1 Selective glucagon-like-peptide-2 (glp-2) analogues |
| 05/15/2008 | CA2669267A1 Methods of using transforming growth factor beata-9 |
| 05/15/2008 | CA2669207A1 Anti-angiogenic compounds |
| 05/15/2008 | CA2669185A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 05/15/2008 | CA2668690A1 A recombinant meso-active thermo-stable protein and the process of design and biosynthesis thereof |
| 05/15/2008 | CA2668487A1 Avian derived erythropoietin |
| 05/15/2008 | CA2668411A1 Alk1 receptor and ligand antagonists and uses thereof |
| 05/15/2008 | CA2668404A1 Process for preparing biodegradable articles |
| 05/15/2008 | CA2666306A1 4-1 bb ligand in inflammatory diseases |
| 05/15/2008 | CA2665369A1 Human placental collagen compositions, and methods of making and using the same |
| 05/15/2008 | CA2664033A1 Use of natural, recombinant and synthetic resilins in cosmetics |
| 05/15/2008 | CA2658610A1 Methods of increasing secretion of polypeptides having biological activity |
| 05/14/2008 | EP1921152A1 Transgenic plants with glycine-betaine specific promoter |
| 05/14/2008 | EP1921150A1 PGRO expression units |
| 05/14/2008 | EP1921089A1 Cytotoxic t-cell epitope peptide and use thereof |
| 05/14/2008 | EP1921088A2 Peptides and related molecules that bind to tall-1 |
| 05/14/2008 | EP1921087A1 Process for the preparation of cyclic peptides |
| 05/14/2008 | EP1920783A1 Recombinant RSV virus expression systems and vaccines |
| 05/14/2008 | EP1920061A1 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 05/14/2008 | EP1920060A2 Insecticidal compositions and methods for making insect-resistant transgenic plants |
| 05/14/2008 | EP1920058A2 Dehydrin gene from avicennia marina responsible for conferring salt tolerance in plants |
| 05/14/2008 | EP1920056A1 Compositions and methods for treating breast cancer |
| 05/14/2008 | EP1920050A1 Improving transglutaminase substrate specificity |
| 05/14/2008 | EP1919957A2 Cd33-specific single-chain immunotoxin and method of use |
| 05/14/2008 | EP1919949A2 Hla fusion molecules and uses thereof |
| 05/14/2008 | EP1919948A2 Methods and means for controlling the endocytosis and subsequent degradation of a cell surface protein |
| 05/14/2008 | EP1919947A1 Therapeutically active alpha-msh analogues |
| 05/14/2008 | EP1919946A1 Transglutaminase variants with improved specificity |
| 05/14/2008 | EP1919945A1 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof |
| 05/14/2008 | EP1919944A2 Modified vegf and pdgf with improved angiogenic properties |
| 05/14/2008 | EP1919943A2 Melanoma-associated mhc class i associated oligopeptides and the uses thereof |
| 05/14/2008 | EP1919942A2 Methods and compositions for enhancing protein folding |
| 05/14/2008 | EP1919941A2 Targeting-enhanced activation of galectins |
| 05/14/2008 | EP1919940A2 Antigenic peptides and their use |
| 05/14/2008 | EP1919939A2 Tight junction modulating peptide components for enhancing mucosal delivery |
| 05/14/2008 | EP1919938A1 Modified spider silk proteins |
| 05/14/2008 | EP1919936A2 Glycerol channel gene and use thereof |
| 05/14/2008 | EP1919935A2 Nucleotide sequences encoding insecticidal proteins |
| 05/14/2008 | EP1919934A2 Serum resistance factors of gram positive bacteria |
| 05/14/2008 | EP1919933A2 Gdnf derived peptides |
| 05/14/2008 | EP1919932A1 Prion inactivation |
| 05/14/2008 | EP1919492A2 Growth hormone secretagogues |
| 05/14/2008 | EP1838727A4 Human cancer suppressor gene, protein encoded therein, expression vector containing same |
| 05/14/2008 | EP1809664B1 A novel process for purification of human growth harmone |
| 05/14/2008 | EP1766021A4 Polynucleotides for the detection of escherichia coli 157:h7 and escherichia coli 0157:nm verotoxin producers |
| 05/14/2008 | EP1723173B1 Il-4/il-13 specific polypeptides and therapeutic uses thereof |